Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_15275 | 116 | 2.42 | Mlig455_053112 | Neo: - Age: Down-Up-Down |
Mlig455_053112 {REF} {Length: 1920} {TRANSSPLICED} {tRNA: Ala(CGC),pseudo, score=31.3} {RNA1509_24967} {RNA1310_40192} {RNA815_19718} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.157 | 2.164 | 0.28215 | 0.93297 | |
RegionR2 | 2.076 | 2.164 | 0.03783 | 0.22535 | |
RegionR3 | 0.824 | 2.164 | 0.38373 | 0.91510 | |
RegionR4 | 0.075 | 2.164 | 0.82932 | 1.00000 | |
RegionR5 | 0.275 | 2.164 | 0.73405 | 1.00000 | |
RegionR6 | 0.595 | 2.164 | 0.54901 | 1.00000 | |
RegionR7 | 1.687 | 2.164 | 0.09771 | 0.59831 | |
RegionR8 | -0.374 | 2.164 | 0.94360 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.04 | 2.164 | 0.99990 | 1.00000 | |
RegenerationR2 | -1.495 | 2.164 | 0.02006 | 0.23261 | |
RegenerationR3 | -1.406 | 2.164 | 0.06788 | 0.43789 | |
RegenerationR4 | -0.057 | 2.164 | 0.93173 | 1.00000 | |
RegenerationR5 | 0.882 | 2.164 | 0.13693 | 0.54740 | |
RegenerationR6 | -0.835 | 2.164 | 0.32478 | 0.67078 | |
RegenerationBL | -4.503 | 2.164 | 0.06353 | 0.29278 | |
RegenerationTP | -1.255 | 2.164 | 0.37036 | 0.80813 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_15275 | 116 | 2.42 | Mlig455_053112 | Neo: - Age: Down-Up-Down |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_053112 {REF} {Length: 1920} {TRANSSPLICED} {tRNA: Ala(CGC),pseudo, score=31.3} {RNA1509_24967} {RNA1310_40192} {RNA815_19718} | |
2. | MligTC455_11174 | 35 | 0.73 | Mlig455_044360 | Neo: - Age: - |
ARFIP2 | 0.98 | - | - | - | - | - | 0.980 | Mlig455_044360 {REF} {Length: 1554} {TRANSSPLICED} {Pfam: Arfaptin-like domain [PF06456.15, score=205.5]} {Human: ENSG00000132254, ARFIP2, ADP ribosylation factor interacting protein 2, [RH, Score=270, Expect=3e-88]; ENSG00000164144, ARFIP1, ADP ribosylation factor interacting protein 1, [RH, Score=268, Expect=5e-87]} {Mouse: ENSMUSG00000030881, Arfip2, ADP-ribosylation factor interacting protein 2, [RH, Score=269, Expect=5e-88]; ENSMUSG00000074513, Arfip1, ADP-ribosylation factor interacting protein 1, [RH, Score=265, Expect=6e-86]; ENSMUSG00000102805, Gm37240, predicted gene, 37240, [RH, Score=262, Expect=1e-86]} {Dmel: FBgn0037884, Arfip, Arfaptin, [RH, Score=262, Expect=3e-85]} {Celegans: WBGene00010040, F54C8.7, [RH, Score=137, Expect=6e-38]} {Smed: dd_Smed_v6_5732_0_1, dd_Smed_v6_5732_0_1, [RH, Score=234, Expect=2e-75]} {RNA1509_22952} {RNA1310_13386} {RNA815_7638} |
3. | MligTC455_34896 | 906 | 18.87 | Mlig455_041044, Mlig455_070071 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.259 Region-enriched R2: 2.266/0.02183 |
0.974 | 0.974 | - | - | - | - | - | Mlig455_041044 {REF} {Length: 7002} {TRANSSPLICED} {Pfam: Fibronectin type III domain [PF00041.23, score=34.4]; Scramblase [PF03803.17, score=18.5]} {Smed: dd_Smed_v6_66647_0_1, dd_Smed_v6_66647_0_1, [Score=113, Expect=8e-28]} {RNA1509_18182} {RNA1310_652.1} {RNA815_333} Mlig455_070071 {REF} {Length: 6980} {TRANSSPLICED} {Pfam: Fibronectin type III domain [PF00041.23, score=34.6]; Scramblase [PF03803.17, score=18.4]} {Smed: dd_Smed_v6_66647_0_1, dd_Smed_v6_66647_0_1, [Score=113, Expect=8e-28]} {RNA1509_18182} {RNA1310_652.1} {RNA815_333} |
|
4. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 0.971 | 0.971 | - | - | - | - | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
5. | MligTC455_53399 | 1311 | 27.32 | Mlig455_000624 | Neo: Int S/G2/M Age: logFC(26M/2M)=0.239 Region-enriched R5: 1.186/0.00070 |
NOP14 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_000624 {REF} {Length: 2599} {Pfam: Nop14-like family [PF04147.14, score=120.8]} {Human: ENSG00000087269, NOP14, NOP14 nucleolar protein, [RH, Score=87.0, Expect=4e-17]} {Mouse: ENSMUSG00000036693, Nop14, NOP14 nucleolar protein, [RH, Score=95.1, Expect=1e-19]} {Dmel: FBgn0010926, l(3)07882, lethal (3) 07882, [RH, Score=77.0, Expect=3e-14]} {Celegans: WBGene00021660, Y48G1A.4, [Score=52.4, Expect=1e-06]} {RNA1509_3372, RNA1509_40021} {RNA1310_10635.2, RNA1509_3372, RNA1509_40021} {RNA1509_3372, RNA1509_40021, RNA815_9085} |
6. | MligTC455_41817 | 273 | 5.69 | Mlig455_050915 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.421/0.00679 |
0.957 | - | - | - | - | - | 0.957 | Mlig455_050915 {REF} {Length: 1810} {TRANSSPLICED} {RNA1509_26844, RNA1509_35213} {RNA1310_16013.2, RNA1509_26844, RNA1509_35213} {RNA1509_26844, RNA1509_35213, RNA815_32730} | |
7. | MligTC455_37861 | 26 | 0.55 | Mlig455_015320 | Neo: - Age: Up-Down-Up |
NBAS | 0.953 | - | - | - | - | - | 0.953 | Mlig455_015320 {REF} {Length: 8596} {TRANSSPLICED} {Pfam: Secretory pathway protein Sec39 [PF08314.13, score=49.8]; Neuroblastoma-amplified sequence, N terminal [PF15492.8, score=33.5]} {Human: ENSG00000151779, NBAS, neuroblastoma amplified sequence, [RH, Score=380, Expect=1e-105]} {Mouse: ENSMUSG00000020576, Nbas, neuroblastoma amplified sequence, [RH, Score=410, Expect=8e-115]} {Celegans: WBGene00008990, smgl-1, [RH, Score=57.8, Expect=1e-07]} {Smed: dd_Smed_v6_7998_0_1, dd_Smed_v6_7998_0_1, [RH, Score=202, Expect=1e-51]} {RNA1509_11685} {RNA1310_353.1} {RNA815_138} |